Stanger, O., Stühlinger, M., Paulweber, B., Schirnhofer, J., & Pachinger, O. (2004). W15.432 Oral folic acid does not reduce plasma concentrations of endogenous NOS inhibitor ADMA in hyperhomocysteinemic subjects. Atherosclerosis (Supplements), 5(1), 100. https://doi.org/10.1016/s1567-5688(04)90431-5
Chicago Style (17th ed.) CitationStanger, O., M. Stühlinger, B. Paulweber, J. Schirnhofer, and O. Pachinger. "W15.432 Oral Folic Acid Does Not Reduce Plasma Concentrations of Endogenous NOS Inhibitor ADMA in Hyperhomocysteinemic Subjects." Atherosclerosis (Supplements) 5, no. 1 (2004): 100. https://doi.org/10.1016/s1567-5688(04)90431-5.
MLA (9th ed.) CitationStanger, O., et al. "W15.432 Oral Folic Acid Does Not Reduce Plasma Concentrations of Endogenous NOS Inhibitor ADMA in Hyperhomocysteinemic Subjects." Atherosclerosis (Supplements), vol. 5, no. 1, 2004, p. 100, https://doi.org/10.1016/s1567-5688(04)90431-5.